Skip to main content
Search
Newsletters
Watchlist
Latest in
Novartis
Follow
You must be logged in to follow.
Log In
Create free account
Latest
international business
Swiss pharmaceutical company Novartis to cut 680 jobs in product development
April 9, 2024
investment ideas
U.S., European bellwethers best expectations, boost investor confidence
October 24, 2023
international business
Novartis plans Sandoz spinoff around Oct. 4, proposes share distribution
August 18, 2023
report on business
Novartis buys Chinook for US$3.2-billion, latest in string of big exits for Canadian biotechs
June 12, 2023
international business
Novartis to spin off generics business Sandoz next year
August 25, 2022
international business
U.S. FDA approves Novartis therapy for prostate cancer
March 23, 2022
advisor stocks
Medtech companies set to bounce as pandemic-delayed surgeries resume
March 9, 2022
world
Swiss drugmaker Novartis to help make Pfizer-BioNTech’s COVID-19 vaccine
January 29, 2021
alberta
Newly approved treatment could save a young child in Edmonton with a rare disease. It costs $2.8-million per dose
December 19, 2020
u.s. business
Novartis CEO says COVID-19 makes valuing takeover targets tougher
August 24, 2020
u.s. business
Novartis wins FDA approval to repurpose leukemia drug against multiple sclerosis
August 20, 2020
u.s. business
Novartis pays $729-million to settle U.S. kickback charges
July 1, 2020
u.s. business
Novartis faces key meeting in U.S. bribery scandal after settling corruption case
June 26, 2020
international business
Novartis to buy U.S. biotech The Medicines Co. for $9.7 billion
November 24, 2019
u.s. business
Swiss drugmaker Novartis must face doctor kickback lawsuit, U.S. judge rules
April 1, 2019